Quarterly report pursuant to Section 13 or 15(d)

STOCK INCENTIVE PLANS AND SHARE-BASED COMPENSATION

v2.4.0.8
STOCK INCENTIVE PLANS AND SHARE-BASED COMPENSATION
9 Months Ended
Dec. 31, 2013
STOCK INCENTIVE PLANS AND SHARE-BASED COMPENSATION [Abstract]  
STOCK INCENTIVE PLANS AND SHARE-BASED COMPENSATION

NOTE 8: STOCK INCENTIVE PLANS AND SHARE-BASED COMPENSATION

Share-Based Compensation

The following table summarizes share-based compensation (in thousands):

    Three Months Ended   Nine Months Ended
    December 31,
2013
  December 31,
2012
  December 31,
2013
  December 31,
2012
Share-based compensation:                                        
       Cost of revenue   $ 509   $ 626   $ 1,560   $ 1,839
       Research and development     862     925     2,638     2,772
       Sales and marketing     994     1,273     3,148     3,603
       General and administrative     1,056     892     2,922     3,515
    $ 3,421   $ 3,716   $ 10,268   $ 11,729
 
 
Share-based compensation by type of award:                        
       Stock options   $ 207   $ 239   $ 647   $ 1,445
       Restricted stock     2,923     2,986     8,629     8,767
       Stock purchase plan     291     491     992     1,517
    $ 3,421   $ 3,716   $ 10,268   $ 11,729

Stock Options

No stock options were granted during the third quarter or first nine months of fiscal 2014 or 2013. The Black-Scholes option pricing model is used to estimate the fair value of stock options.

Restricted Stock

The fair value of restricted stock units ("RSUs") granted is the intrinsic value as of the respective grant date since the restricted stock units are granted at no cost to the employees. The weighted-average grant date fair values of RSUs granted during the third quarter and first nine months of fiscal 2014 were $1.25 and $1.40, respectively. The weighted-average grant date fair values of RSUs granted during the third quarter and first nine months of fiscal 2013 were $1.44 and $1.99, respectively

During the third quarter of fiscal 2014, we granted 0.2 million RSUs with performance conditions ("performance RSUs") and the fair value of the performance RSUs at the grant date was $0.2 million. Performance RSUs will become eligible for vesting based on Quantum achieving certain revenue and operating income targets through the end of fiscal 2014. Share-based compensation expense for performance RSUs is recognized when it is probable that the performance conditions will be achieved. As of December 31, 2013, no share-based compensation expense was recognized for the performance RSUs.

During the second quarter of fiscal 2014, we granted 0.8 million RSUs with market conditions ("market RSUs") and estimated the fair value of these market RSUs using a Monte Carlo simulation model. The number of market RSUs is dependent on Quantum's common stock achieving certain 60-day average stock price targets as of specified dates, which vest immediately to two years after the specified dates.

The Monte Carlo model requires the input of assumptions including expected volatility, risk-free interest rate and expected term in order to simulate a large number of possible outcomes to provide an estimated fair value of the market RSUs. We used an expected volatility of 66%, a risk free interest rate of 0.5% and expected terms of ten months, twenty two months and thirty four months that mirrors the various vesting dates of the awards. The estimated fair value of the market RSUs was $0.7 million which will be recognized over the respective vesting periods of the awards.

Stock Purchase Plan

Under the Stock Purchase Plan, rights to purchase shares are typically granted during the second and fourth quarter of each fiscal year. The value of rights to purchase shares granted in the first nine months of fiscal 2014 and fiscal 2013, respectively, was estimated at the date of the grant. The weighted-average grant date fair values and the assumptions used in calculating fair values for the nine months ended December 31, 2013 and 2012 are as follows:

    Nine Months Ended
    December 31,
2013
  December 31,
2012
Option life (in years)         0.5           0.5  
Risk-free interest rate     0.07 %     0.15 %
Stock price volatility            47.65 %            74.81 %
Weighted-average grant date fair value   $ 0.47     $ 0.51  

Stock Activity

Stock Options

A summary of activity relating to our stock options follows (options and aggregate intrinsic value in thousands):

    Options   Weighted-
Average
Exercise Price
  Weighted-
Average
Remaining
Contractual Term
  Aggregate
Intrinsic Value
Outstanding as of March 31, 2013       16,050         $ 2.14                  
       Exercised   (535 )     0.99          
       Forfeited   (1,108 )     2.20          
       Expired   (3,011 )     2.07          
Outstanding as of December 31, 2013   11,396     $ 2.21   1.66   $ 1,031
Vested and expected to vest at December 31, 2013   11,369     $ 2.20   1.66   $ 1,031
Exercisable as of December 31, 2013          10,944     $        2.19   1.56   $        1,027

Restricted Stock

A summary of activity relating to our restricted stock follows (shares in thousands):

    Shares   Weighted-Average
Grant Date
Fair Value
Nonvested at March 31, 2013       9,887         $ 2.43
       Granted   7,751       1.40
       Vested   (4,241 )     2.40
       Forfeited   (1,041 )     2.06
Nonvested at December 31, 2013          12,356     $ 1.83